Akt inhibitor MK‑2206 reduces pancreatic cancer cell viability and increases the efficacy of gemcitabine

Zhanshan Wang(Chinese Research Academy of Environmental Sciences), Zhengjun Qiu(Shanghai First People's Hospital)
Oncology Letters
January 14, 2020
Cited by 31


Related Papers